Abstract
Many frontiers in the modeling of the ventilatory system and its control are at the cellular and molecular levels. The carotid body’s response to hypoxia is no exception to this. A commonly accepted model of the carotid body’s chemotransduction of hypoxia presents the transmitter-laden glomus cell being depolarized by the hypoxic challenge in as-yet-to-bedetermined processes. This depolarization activates voltage-gated calcium channels with the subsequent entrance of extracellular calcium. This event, in turn, precipitates the release of several transmitters. Many investigators have reported the hypoxia-generated release of catecholamines from the carotid body. And recently we have reported the release of acetylcholine (ACh) from the cat carotid body during hypoxia1. These transmitters are presumed to bind to “postsynaptic” receptors located on the apposed sensory afferent fibers which have their cell bodies in the petrosal ganglion with their axons terminating in nucleus tractus solitarii. The transmitters are also presumed to bind to “presynaptic” autoreceptors on the glomus cells. Over the last decade our working hypothesis has been that ACh is the (or at least one) critically important excitatory transmitter. And in the mid 1990s we generated some neurophysiological recordings2 which suggested the presence of both M1 and M2 muscarinic receptors in the carotid body. The data could not answer whether the receptors were located postsynaptically, presynaptically, or both. Since then we have reported preliminary results suggesting that they are at least located on the glomus cell.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
R.S. Fitzgerald, M. Shirahata, H-Y. Wang. Acetylcholine release from cat carotid bodies. Brain Res. 84: 53–61 (1999).
R.S. Fitzherald, M. Shirahata, T. Ide. Further cholinergic aspects of carotid body chemotransduction of hypoxia in cats. J. Appl. Physiol. 82 : 819–827 (1997).
B. Dinger, T. Hirano, S.J. Fidone. Autoradiographic localization of muscarinic receptors in rabbit carotid body. Brain Res. 367: 328–331 (1986).
T. Hirano, B. Dinger, K. Yoshizaki, C. Gonzalez, S. Fidone. Nicotinic versus muscarinic binding sites in cat and rabbit carotid bodies. Biol. Signals 1: 143–149 (1992).
N. DeKlippel, S. Sarre, G. Ebinger, Y. Michotte. Effect of MI- and M2- muscarinic drugs on striatal dopamine release and metabolism: an in vivo microdialysis study comparing normal and 6-hydroxydopamine-lesioned rats. Brain Res. 630: 57–64 (1993).
I. Smolders, L. Bogaert, G. Ebinger, Y. Michotte. Muscarinic modulation of striatal dopamine, glutamate, and GABA release, as measured with in vivo microdialysis. J. Neurochem. 68: 1942–1948 (1997).
J.S. de Belleroche, I.M. Gardiner. Cholinergic action in the nucleus accumbens: modulation of dopamine and acetylcholine release. Br. J. Pharmac. 75: 359–365 (1982).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wang, HY.J., Fitzgerald, R.S. (2001). Muscarinic Receptors Influence Catecholamine Release from the Cat Carotid Body During Hypdxia. In: Poon, CS., Kazemi, H. (eds) Frontiers in Modeling and Control of Breathing. Advances in Experimental Medicine and Biology, vol 499. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1375-9_7
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1375-9_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5522-9
Online ISBN: 978-1-4615-1375-9
eBook Packages: Springer Book Archive